Focus:
Analysis
-
2 July 2020
The impact of Covid-19 on the global clinical supply chain
It goes without saying that the coronavirus pandemic has had an unprecedented impact on economies and industries worldwide, but within the pharmaceutical space, Covid-19 has completely re-shaped the clinical supply...
-
29 June 2020
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
After announcing a partnership to assess the safety of potential Covid-19 drugs, TRHC and Regence bosses discuss the benefits offered by virtual clinical trials
-
24 June 2020
Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?
Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organisations to smaller functional service providers. Here, Arena International portfolio director Alexander...
-
19 June 2020
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Having grown into one of the biggest companies in the biotech sphere since its inception in 1988, Regeneron is now working to develop a Covid-19 treatment
-
18 June 2020
Dealing with the unexpected: Covid-19 and risk management
Major global events such as the ongoing Covid-19 pandemic can cause significant problems for clinical trials and pharma research programmes. Oncoinvent head of clinical operations Helén Johansen Blanco shares her...
-
16 June 2020
Blockchain enables machine learning and AI to drive a hyper-efficient trial
What can the blockchain offer to time- and cost-intensive modern clinical trials? Novapeutics CEO Frank Leu reviews today's standard clinical trial flow and how blockchain technologies could provide a much-needed...
-
15 June 2020
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab as a potential Covid-19 treatment
-
8 June 2020
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
Alongside Pfizer, Merck, Johnson & Johnson and AstraZeneca, Moderna was recently selected as a Covid-19 vaccine 'finalist' in the US
-
2 June 2020
‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks
Hydroxychloroquine, a chloroquine drug, has temporarily been dropped from global WHO trials for Covid-19 treatments due to safety concerns
-
29 May 2020
UK position in global clinical trials sector could receive boost after Covid-19, says industry boss
The RECOVERY and ACCORD studies taking place across the UK right now are some of the biggest clinical trials for Covid-19 treatments anywhere in the world